Literature DB >> 17428670

Inhibitory effect of obovatal on the migration and invasion of HT1080 cells via the inhibition of MMP-2.

Su-Kyung Lee1, Hyo Kon Chun, Jae Young Yang, Dong Cho Han, Kwang-Hee Son, Byoung-Mog Kwon.   

Abstract

Because the activation of matrix metalloproteinases (MMP) is a key factor in the metastatic process, compounds with the ability to inhibit MMP activity have a potential in the treatment of tumor. From the examination of 2000 plant extracts, obovatal isolated from the extract of the leaves of Magnolia obovata THUNB was a potent inhibitor of MMP-2 enzyme in vitro. In human fibrosarcoma cells (HT1080) activated with MMP-2, obovatal inhibited MMP-2 enzyme activity and expression. In addition, the compound blocked migration and invasion of the cells. This study demonstrates that obovatal exerts its anticancer effects through blocking migration and invasion by inhibition of MMP-2 expression and activity, and also will be a good lead molecule for the development of anti-tumor drug.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17428670     DOI: 10.1016/j.bmc.2007.03.081

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

Review 1.  Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents.

Authors:  Mélanie Poivre; Pierre Duez
Journal:  J Zhejiang Univ Sci B       Date:  2017 Mar.       Impact factor: 3.066

2.  Sinomenine influences capacity for invasion and migration in activated human monocytic THP-1 cells by inhibiting the expression of MMP-2, MMP-9, and CD147.

Authors:  Yang-qiong Ou; Li-hua Chen; Xue-jun Li; Zhi-bin Lin; Wei-dong Li
Journal:  Acta Pharmacol Sin       Date:  2009-03-23       Impact factor: 6.150

3.  Compounds isolated from Ageratum houstonianum inhibit the activity of matrix metalloproteinases (MMP-2 and MMP-9): An oncoinformatics study.

Authors:  Anupriya Verma; Syed Mohd Danish Rizvi; Sibhghatulla Shaikh; Mohd Afaque Ansari; Shazi Shakil; Fauzia Ghazal; Mohd Haris Siddiqui; Mohd Haneef; Ajijur Rehman
Journal:  Pharmacogn Mag       Date:  2014-01       Impact factor: 1.085

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.